Good, but not fantastic. Will have to wait until mid year for the final results. I would've liked more info in regards to the "moderate" adverse effects alluded to in the update.
Point is that cannabinoids work for a good proportion of patients....some tough times ahead for MC patients, clinicians wont jump on the MC band wagon just yet.
Ann: PhytoTech Therapeutics Phase 2 Clinical Trial Update, page-4
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
